Skip to content
  1. Home
  2. Our Company
  3. In Front of Cancer: Mary’s Story
Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson sitting at a table being interviewed

In Front of Cancer: Mary’s Story

Each day, we are working toward our ambition to get in front of cancer.

For Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson, this work is deeply personal. Her story, and the stories of patients everywhere, inspire and remind us why we will never settle until the disease is behind everyone.

More from Johnson & Johnson

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

This scientist develops targeted treatments for cancer—here’s what drives and inspires him

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.